Dwight M. Morrow

发表

GPCR drug discovery through the exploitation of allosteric drug binding sites.

S. Rees, Dwight M. Morrow, T. Kenakin, 2002, Receptors & channels.

3-Urea-1-(phenylmethyl)-pyridones as novel, potent, and selective EP3 receptor antagonists.

Dwight M. Morrow, K. Evans, Yue H. Li, 2010, Bioorganic & medicinal chemistry letters.

Structure-activity relationship studies of novel 3-oxazolidinedione-6-naphthyl-2-pyridinones as potent and orally bioavailable EP3 receptor antagonists.

Carl A. Brooks, Dwight M. Morrow, P. Eidam, 2011, Bioorganic & medicinal chemistry letters.

Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.

Dwight M. Morrow, A. Sulpizio, R. Nagilla, 2009, Bioorganic & medicinal chemistry letters.

Modulation of bladder function by prostaglandin EP3 receptors in the central nervous system.

Dwight M. Morrow, J. Hieble, N. Laping, 2008, American journal of physiology. Renal physiology.

Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists.

Carl A. Brooks, D. Holt, Dwight M. Morrow, 2010, ACS medicinal chemistry letters.

M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.

Zehong Wan, Dwight M. Morrow, H. Sarau, 2009, Bioorganic & medicinal chemistry letters.

Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.

Dwight M. Morrow, Wei-Chang Fu, H. Sarau, 2008, Bioorganic & medicinal chemistry letters.

Novel KV7 ion channel openers for the treatment of epilepsy and implications for detrusor tissue contraction.

Dwight M. Morrow, G. Higgins, Y. Matsuoka, 2018, Bioorganic & medicinal chemistry letters.

Benzofuran-substituted urea derivatives as novel P2Y(1) receptor antagonists.

Dwight M. Morrow, N. Aiyar, J. Erhardt, 2010, Bioorganic & medicinal chemistry letters.

Tetrahydro-4-quinolinamines identified as novel P2Y(1) receptor antagonists.

Dwight M. Morrow, N. Aiyar, P. Li, 2008, Bioorganic & medicinal chemistry letters.

A Novel Neuroprotective Small Molecule for Glial Cell Derived Neurotrophic Factor Induction and Photoreceptor Rescue.

Dwight M. Morrow, Shenshen Cai, M. Young, 2017, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Discovery of novel and long acting muscarinic acetylcholine receptor antagonists.

Dwight M. Morrow, Wei-Chang Fu, H. Sarau, 2008, Journal of medicinal chemistry.

The discovery of potent blockers of the canonical transient receptor channels, TRPC3 and TRPC6, based on an anilino-thiazole pharmacophore.

D. Holt, Dwight M. Morrow, R. Willette, 2013, Bioorganic & Medicinal Chemistry Letters.

A novel approach applying a chemical biology strategy in phenotypic screening reveals pathway-selective regulators of histone 3 K27 tri-methylation.

Pankaj Agarwal, Dwight M. Morrow, Q. Xie, 2014, Molecular bioSystems.

Oxazolidinones as novel human CCR8 antagonists.

Dwight M. Morrow, H. Sarau, J. Foley, 2007, Bioorganic & medicinal chemistry letters.

Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.

Zehong Wan, Dwight M. Morrow, H. Sarau, 2008, Journal of Medicinal Chemistry.

A High-Content Imaging Screen for Cellular Regulators of β-Catenin Protein Abundance

Pankaj Agarwal, Dwight M. Morrow, Zining Wu, 2016, Journal of biomolecular screening.